Back
TScan Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
38
TCRX
TScan Therapeutics, Inc.
Last Price:
$1.07
Seasonality Move:
1.49%
7 Day Trial
ALL ACCESS PASS
$
7
TScan Therapeutics, Inc. Stock Forecast
-
Is TScan Therapeutics, Inc. Stock Undervalued?The current TScan Therapeutics, Inc. [TCRX] share price is $1.06. The Score for TCRX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
TCRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will TScan Therapeutics, Inc. Stock Go Up Next Year?
Data Unavailable
TScan Therapeutics, Inc. Stock Rating
Data Unavailable
TScan Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
tscan.com
52-Week Data
52-Week High:
3.21
52-Week Low:
0.88
Prediction Charts
Market Cap:
60.2M
Price in USD:
1.06
Volume:
626.7K
Beta:
1.05
Technical Analysis
SMA50:
1.33
SMA100:
1.59
SMA200:
1.56
52-Wk Change:
-65.92%
Stock Predictions
-
Is TScan Therapeutics, Inc. stock public?Yes, TScan Therapeutics, Inc. is a publicly traded company.
-
What is the TScan Therapeutics, Inc. stock quote today?The TScan Therapeutics, Inc. stock price is 1.06 USD today.
-
How to buy TScan Therapeutics, Inc. stock online?You can buy TScan Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-8 | 1.09 | 1.00 | 1.11 | 0.91 |
| Dec-9 | 1.00 | 1.02 | 1.05 | 1.00 |
| Dec-10 | 1.00 | 1.03 | 1.05 | 0.99 |
| Dec-11 | 1.04 | 1.07 | 1.09 | 1.01 |
| Dec-12 | 1.06 | 1.01 | 1.08 | 1.01 |
| Dec-15 | 1.02 | 0.96 | 1.05 | 0.96 |
| Dec-16 | 0.97 | 0.95 | 0.98 | 0.94 |
| Dec-17 | 0.97 | 0.93 | 0.99 | 0.92 |
| Dec-18 | 0.96 | 0.93 | 0.98 | 0.91 |
| Dec-19 | 0.93 | 0.90 | 0.94 | 0.88 |
| Dec-22 | 0.90 | 0.90 | 0.96 | 0.89 |
| Dec-23 | 0.91 | 0.91 | 0.93 | 0.90 |
| Dec-24 | 0.97 | 1.04 | 1.07 | 0.96 |
| Dec-26 | 1.06 | 1.06 | 1.07 | 0.98 |
TScan Therapeutics, Inc. Earnings
Data Unavailable
TScan Therapeutics, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and an increase next year of $0.24 per share.
* TScan Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.